Clinical Research Directory
Browse clinical research sites, groups, and studies.
AI-CCTA for Predicting Cardiovascular Events in CAD
Sponsor: Nanjing First Hospital, Nanjing Medical University
Summary
This multicenter, retrospective registry study aims to evaluate the value of artificial intelligence (AI)-derived coronary CT angiography (CCTA) parameters in predicting long-term cardiovascular events in patients with coronary artery disease (CAD). We plan to enroll 3,000 patients from five tertiary hospitals who underwent both CCTA and invasive coronary angiography (ICA) within 90 days. Using ICA and quantitative flow ratio (QFR) as reference standards, we will compare the diagnostic performance of different commercial AI software platforms. Furthermore, we will investigate the association between AI-extracted CCTA multidimensional parameters-including high-risk plaque features, CT-derived fractional flow reserve (CT-FFR), and pericoronary fat attenuation index (FAI)-and major adverse cardiac events (MACE) during over one year of follow-up. We will also explore how lipid-lowering therapies, antiplatelet regimens, and inflammatory biomarkers modify these predictive relationships. This study is expected to provide imaging evidence for personalized risk stratification and optimized clinical decision-making in CAD management.
Official title: Multicenter Al-derived CCTA Parameters for Predicting Long-term Cardiovascular Events in Coronary Artery Disease: A Retrospective Registry Study
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
3000
Start Date
2026-06-01
Completion Date
2026-10
Last Updated
2026-09-21
Healthy Volunteers
No
Interventions
No intervention
This is an observational study. No specific interventions are administered by the research team. Participants receive standard diagnostic and therapeutic procedures as per routine clinical practice. The study involves retrospective analysis of existing medical records (CCTA and ICA data) to evaluate the association between AI-derived metrics and clinical outcomes.
Locations (1)
Nanjing First Hospital, Nanjing Medical University
Nanjing, Jiangsu, China